SCHEMBL26833293

SCHEMBL26833293

c1ccc2cc(-c3nc4cccnc4o3)ccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
HSD17B10 Q99714 4/20 0.49
KDM4E B2RXH2 4/20 0.49
TP53 P04637 3/20 0.49
HPGD P15428 3/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
TSHR P16473 2/20 0.48
MAPT P10636 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
LMNA P02545 1/20 0.48
PKM P14618 1/20 0.48
KLF5 Q13887 1/20 0.48
SGMS2 Q8NHU3 8/20 0.46
CYP1A2 P05177 3/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
NOTUM Q6P988 1/20 0.44
UTRN P46939 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27200964 0.87 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HSD17B10KDM4ETP53
SCHEMBL27424628 0.85 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2HSD17B10KDM4ETP53
SCHEMBL27424627 0.85 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2HSD17B10KDM4ETP53
SCHEMBL27424622 0.84 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HSD17B10KDM4ETP53
SCHEMBL13998685 0.83 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2HSD17B10KDM4ETP53
SCHEMBL13052998 0.83 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2HSD17B10KDM4ETP53
SCHEMBL12910410 0.82 HPGD (0.56) ALDH1A1SMN1; SMN2HSD17B10KDM4ETP53
SCHEMBL27423977 0.82 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HSD17B10KDM4ETP53
SCHEMBL27424131 0.82 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HSD17B10KDM4ETP53
SCHEMBL26833804 0.82 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2HSD17B10KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 US disclosed
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF AHR, ORAI3, WNT3 ALDH1A1 1797/4885SMN1; SMN2 3344/4885HSD17B10 2121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.